CONCENTRATION	9 Months Ended
Apr. 30, 2024
CONCENTRATION
CONCENTRATION	NOTE 8 – CONCENTRATION Discontinue Revenue On March 1, 2022, the Company entered in a consulting agreement in the field of Healthcare with a monthly fee of $8,333, with First DP Ventures, LP. The services were performed by a member of the Company’s board of directors pursuant to an Employment Contract. The consulting agreement was terminated on March 29,2024. During the nine months ended April 30, 2024 and 2023, all discontinued revenue of $66,667 and $75,001 and as of April 30, 2024 and July 31, 2023, the accounts receivable of $0 and $8,333 were derived from one customer, respectively. Discontinue Cost of Revenue During the nine months ended April 30, 2024, and 2023, the discounted cost of revenue of $62,743 and $71,771 was for the payroll expenses related to a member of the Company’s board of directors, who performed the consulting services.

CONCENTRATION

9 Months Ended

Apr. 30, 2024

NOTE 8 – CONCENTRATION

Discontinue Revenue

On March 1, 2022, the Company entered in a consulting agreement in the field of Healthcare with a monthly fee of $8,333, with First DP Ventures, LP. The services were performed by a member of the Company’s board of directors pursuant to an Employment Contract. The consulting agreement was terminated on March 29,2024. During the nine months ended April 30, 2024 and 2023, all discontinued revenue of $66,667 and $75,001 and as of April 30, 2024 and July 31, 2023, the accounts receivable of $0 and $8,333 were derived from one customer, respectively.

Discontinue Cost of Revenue

During the nine months ended April 30, 2024, and 2023, the discounted cost of revenue of $62,743 and $71,771 was for the payroll expenses related to a member of the Company’s board of directors, who performed the consulting services.